AIMOVIG vs LOTENSIN HCT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. AIMOVIG and LOTENSIN HCT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	LOTENSIN HCT
Rating	72/100	New
Pharmacy pays	—	~$2.25 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Manufacturer	Amgen Inc	Validus Pharms
Dosage forms	Injectable, Solution	Tablet
Drug class	—	—
Boxed warning	None	Boxed warning
Half-life	—	about 6 to 15 hours (the label reports a range, not a single number)

aimovig lotensin hct

Rating

72/100

New

Pharmacy pays

—

~$2.25 /30

Type

Active ingredient

ERENUMAB-AOOE

BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Manufacturer

Amgen Inc

Validus Pharms

Dosage forms

Injectable, Solution

Tablet

Drug class

—

Boxed warning

None

Boxed warning

Half-life

—

about 6 to 15 hours (the label reports a range, not a single number)

Frequently asked questions

What is the difference between Aimovig and Lotensin Hct?

Aimovig contains Erenumab-Aooe, while Lotensin Hct contains Benazepril Hydrochloride and Hydrochlorothiazide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.